Researchers from Canada reviewed the results of 26 trials to determine which of the weight loss jabs are the most effective for obese adults who do not have diabetes.

In one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re both once-a-week injectable drugs designed to help patients with type 2 diabetes manage blood sugar.

It's not just celebrities and TikTok creators jumping on the weight loss drug hype - more than 500,000 people in the UK are now taking either Mounjaro or Wegovy, with experts predicting a nationwide fall in obesity rates.

Each brand has its own formula for helping users achieve their weight loss goals. Their methods include remote healthcare providers, compounded GLP-1 and other injectables, oral medication and resources for making small changes to your routine. The aim of these methods is to offer sustainable options toward a healthier lifestyle.

From science-backed supplements to insurance-covered nutrition therapy, here's your complete guide to effective weight loss when Ozempic isn't an option.

More than 500,000 people in the UK are now on the drugs and could lose between 15-20% of their weight in just a few months. But around 95% of all patients using the medication are buying it privately, while the rollout on the NHS remains slow.

Drugs like Ozempic, Wegovy and Mounjaro are changing the game for weight loss. GLP-1 medications were originally intended to treat type 2 diabetes, but a growing number of people are using it for weight loss.